Promoting Organ Donor Registration in Family Physician Offices

Status Completed

Clinical Trial Summary

This study evaluates the effects of using reception staff to prompt patients by providing a pamphlet and an opportunity to register in the waiting room via a mobile tablet on deceased organ donor registration rates.

Clinical Trial Description

Background: There is a worldwide shortage of organs available for transplant, leading to preventable morbidity and mortality. While the majority of the general public in many countries support organ donation, actual donor registration rates are substantially out of step with these views. For instance, in Canada most Canadians support organ donation but less than 25% in most provinces have registered. The family physician office is a promising yet underused setting in which to address known barriers and facilitators to registration for deceased organ and tissue donation and to provide an immediate opportunity to register while in the waiting room for those wanting to do so. Methods/Design: The investigators aim to evaluate the effects of having reception staff in family physician offices to prompt patients upon check-in with an educational pamphlet using a cluster, stepped-wedge randomized design. A mobile tablet will also be added to the waiting area to provide patients with the immediate opportunity to register. Family physicians are also provided with an educational booklet and encouraged to discuss organ donation with their patients. The investigators will use behaviour change techniques designed to address previously anticipated barriers and enablers to organ and tissue donation registration. The investigators will evaluate the effectiveness of the intervention conducted in six family physician offices in Ontario, Canada. Following a two-week baseline control period, offices will cross sequentially into the intervention arm in a random sequence at two-week intervals until all offices deliver the intervention (baseline + two weeks for each of six offices). The primary outcome will be the proportion of patients that have registered for deceased organ donation following in the 7 days following their office visit, using routinely collected registry data (i.e. administrative databases). The investigators will also conduct a qualitative post-trial process evaluation will assess reception staff and family physicians experiences with the intervention. Discussion: Promoting organ and donor registration remains an important strategy for organ procurement organizations and patients worldwide. The results of this trial will inform a provincial roll-out strategy to promote organ donation in family physician offices. ;

Study Design

Related Conditions & MeSH terms

Death
Organ Donation
Registration for Deceased Organ Donation

Clinical Trial Details

NCT number	NCT03213171
Study type	Interventional
Source	Lawson Health Research Institute
Contact
Status	Completed
Phase	N/A
Start date	September 27, 2017
Completion date	April 1, 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03816241` - Mechanisms of Nudges on Families' Decision-Making Process	N/A
Completed	`NCT04007419` - Health Promoters and Organ Donation	N/A
Completed	`NCT01969864` - University Student Intervention to Increase Organ Donation	N/A
Completed	`NCT02836301` - RCT- Comparing Testimonial Versus Documentary Organ Donation Video Education	N/A
Completed	`NCT03612024` - Bernese Next of Kin Survey Following Organ Donation Request
Completed	`NCT03179020` - Donation Network to Optimize Organ Recovery Study	N/A
Recruiting	`NCT05660252` - Effect of Collaborative Requesting on DCD Refusal Rates: Randomized Controlled Trial	N/A
Terminated	`NCT03439995` - Goal of Open Lung Ventilation in Donors	N/A
Completed	`NCT02525510` - Deceased Organ Donor Interventions to Protect Kidney Graft Function	N/A
Completed	`NCT02854267` - Organ Procurement : Usefulness of a Guide for Meeting With the Next of Kin
Completed	`NCT02138227` - A Randomized Trial of the Early Referral and Request Approach (ERRA) Intervention to Increase Consent to Organ Donation	N/A
Recruiting	`NCT04661787` - Donation Advisor Clinical Decision Support Tool Study
Completed	`NCT02825862` - Investigating Affective Attitude Question-behaviour Effects on Intention to Become an Organ Donor	N/A
Recruiting	`NCT03786991` - EPI-STORM: Cytokine Storm in Organ Donors
Active, not recruiting	`NCT03850847` - Understanding Decision Making in the Intensive Care Unit: a National Study
Recruiting	`NCT04734574` - Methods of Confirmation of Brain Death

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.